Board Meeting As On 14Th February, 2018
Pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015, Kindly note that the Meeting of the Board of Directors of the Company will be held on Wednesday, February 14, 2018 to consider and take on record, among other things Unaudited Financial Results of the Company for the quarter ended December 31, 2017. Shareholding for the Period Ended December 31, 2017
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here Shareholding for the Period Ended December 31, 2017
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here Updates
With respect to your email received having subject: Discrepancies in Financial Result of the Company for the Quarter endedSeptember 2017 on 21st December, 2017, we are herewith attaching the regrouped/ revised un-audited financial statements for the relevant period that has some minor re-classifications of categories (i.e. Finance Costs & Other Income) as per Schedule III of the Companies Act, 2013 and the changes so made do not have... Statement Of Investor Complaints For The Quarter Ended 31St December, 2017
Statement of Investor Complaints- Regulation 13 of SEBI (LODR) Regulations, 2015- Quarter ended 31st December, 2017 Resignation of Company Secretary / Compliance Officer
Resignation of the Company Secretary/ Compliance Officer of the Company w.e.f 21st December, 2017. Board Meeting Of The Company For The Quarter Ended September 30, 2017 To Be Held On 14Th November, 2017
Pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015, the company informs that a meeting of Board of Directors of the Company will be held on Tuesday, 14th day of November, 2017 Compliance Certificate For The Period Ended September 30, 2017
Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 for half year ended September 30, 2017